Login to Your Account

Pharma: Other News To Note

Monday, February 11, 2013
• Taro Pharmaceutical Industries Ltd., of Yakum, Israel, and Sun Pharmaceutical Industries Ltd., of Mumbai, India, agreed to terminate their merger agreement of August 2012, which would have given shareholders of Taro $39.50 per share upon closing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription